A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors
Novartis
Novartis
Prelude Therapeutics
Incyte Corporation
Novartis
Novartis
BeiGene
Seagen Inc.
Molecular Templates, Inc.
Eisai Inc.
Atreca, Inc.
Boston Scientific Corporation